HIL is developing a new class of ultra-compact, high-performance cancer Proton Therapy systems. We bring 21st-century technologies – nano-tech, high-intensity lasers and advanced magnetics – to a field largely dominated by developments made in the 1930’s and 1940’s. Thus HIL is paving the way, for the first time, to truly cost-effective proton therapy solutions.
HIL Medical, Ltd. is a privately held company, funded by the Hebrew University in Jerusalem, Israel’s Office of the Chief Scientist and wide, global base of private investors. We are headquartered in Jerusalem, Israel.